GE HealthCare and Ascension have partnered to improve clinical and operational outcomes within the latter’s national network.

AngioDynamics has enrolled the first subject in the AMBITION BTK trial designed to assess the Auryon Atherectomy System.

ALZpath’s pTau217 antibody is drawing significant attention at this year’s Alzheimer's Association International Conference (AAIC), taking place in Toronto, Canada, from 27-31 July. The biomarker ...

Stereotaxis has received US Food and Drug Administration (FDA) clearance for its electrophysiology (EP) catheter MAGiC Sweep.

Cognito Therapeutics has presented new data demonstrating its Spectris neuromodulation device’s potential to slow cognitive decline and preserve white matter in patients with mild to moderate ...

Healthcare firm OSR Holdings (OSRH) has signed a term sheet to acquire South Korea's medical device company, Woori IO (WORIO).

Olympus and private equity firm Revival Healthcare Capital have co-founded a new endoluminal robotics startup named Swan EndoSurgical Robotics.

Capsule endoscopy devices have advantages over traditional endoscopes, offering improved patient comfort and fewer complications.

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...

MeMed has developed MeMed BV Flex, a rapid infection differentiation test that distinguishes between bacterial and viral infections.

Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas Wearable Injector for subcutaneous delivery of biologics.